Pay in 4 interest-free payments of $200.38 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Each of these strategies involves negative effects: significant yield loss
biocompatibility and sterility
exon 6 of DMD
The unprecedented transformation efficiency of E
ClearColi-BL21(DE3) Electrocompetent Cells (DUOs) size:12 rxns Each of these strategies involvesClearColi BL21(DE3) Electrocompetent Cells Eliminate endotoxin at the source Genetically modified LPS does not trigger endotoxic response in human cells Ideal for mammalian cell immunogenicity testing, toxicity assays, and therapeutic protein drug discovery Useful for membrane and lipid binding protein production Protein expression similar to BL21(DE3) cells without requiring downstream endotoxin removal Reduce false positives in cytokine assays,